Physician profile
Candice E Swerdlow
NPI 1588054266
$702.82
in general payments reported to CMS, 2019-2025
11 companies · $69.48 in 2025
The $69.48 reported for 2025 was more than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $110 · 2023: $121 · 2024: $402 · 2025: $69.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $253.26 | 2022-2025 | Entyvio, Gattex |
| Becton, Dickinson and Company | $186.11 | 2024 | |
| Vertos Medical, INC. | $64.15 | 2023-2024 | Mild Device Kit |
| Ardelyx, INC. | $59.38 | 2024-2025 | Ibsrela |
| Micro-Tech Endoscopy USA, INC. | $27.92 | 2024 | Sureclip |
| Ferring Pharmaceuticals INC. | $22.53 | 2022 | |
| Nevro Corp. | $22.51 | 2022 | |
| Janssen Biotech, INC. | $19.58 | 2025 | Tremfya |
| Curonix LLC | $18.00 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $15.36 | 2022 | |
| Aimmune Therapeutics, INC. | $14.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Swerdlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.